Christopher Peetz, CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 12,026 shares at $26.19 ($315K) on 2024-02-02, disclosed to the SEC on 2024-02-05.
Open-market sale of $315k MIRM by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.19 | 6,013 | $157K | 50.0% |
| 2 | $26.19 | 6,013 | $157K | 50.0% |
| Total | $26.19 avg | 12,026 | $315K | 100% |
| Filing → |
| MIRM | SELL | 2026-07-08 | $2.4M | — | Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |